Interpretable machine learning for preoperative prediction of WHO/ISUP grade in clear cell renal cell carcinoma using contrast-enhanced CT–derived extracellular volume fraction
- 1Department of medical imaging, Affiliated Huaian No.1 People’s Hospital of Nanjing Medical University
- 2Department of Medical Imaging, Siyang First People’s Hospital
Abstract
Objective: To develop and validate an interpretable machine learning (ML) model that integrates extracellular volume fraction (ECV) derived from contrast-enhanced CT with clinical and imaging features for preoperative prediction of World Health Organization/International Society of Urological Pathology (WHO/ISUP) grade in clear cell renal cell carcinoma (ccRCC).
Materials and methods: A retrospective cohort of 263 patients with pathologically confirmed ccRCC from two institutions was analyzed. Patients from Hospital A (n=184) were randomly divided into training (n=128) and internal validation (n=56) cohorts, while patients from Hospital B (n=79) served as an independent external validation cohort. CT-derived ECV, arterial enhancement fraction (AEF), and conventional imaging features were extracted. Six machine learning models (Logistic Regression [LR], eXtreme Gradient Boosting [XGBoost], Gaussian Naive Bayes [GNB], Support Vector Machine [SVM], K-Nearest Neighbors [KNN], Light Gradient Boosting Machine [LightGBM]) were constructed, and the best-performing model was identified based on bootstrap resampling. Model interpretability was assessed using SHapley Additive exPlanations (SHAP).
Results: Tumor size (low-grade: 4.99 ± 1.98 cm; high-grade: 6.20 ± 2.72 cm, P = 0.002), ECV (low-grade: 0.46 ± 0.09; high-grade: 0.57 ± 0.12, P<0.001), and AEF (low-grade: 1.37 ± 0.24; high-grade: 1.56 ± 0.25, P<0.001) were significantly higher in high-grade ccRCC, while hematocrit (HCT, low-grade: 0.41 ± 0.05; high-grade: 0.38 ± 0.06, P<0.001) was lower. The optimal LR model achieved robust performance: training cohort AUC = 0.995 (95% CI: 0.990–0.999), internal validation AUC = 0.903 (95% CI: 0.818–0.988), external test AUC = 0.857 (95% CI: 0.756–0.958). SHAP analysis showed ECV, tumor diameter, and AEF were the top 3 predictors.
Conclusion: An interpretable ML model incorporating CT-derived ECV and imaging features effectively predicts preoperative WHO/ISUP grade of ccRCC, providing a noninvasive tool for individualized risk stratification and clinical decision-making.
Related
- Machine learning-based prediction of lymph node metastasis in papillary thyroid carcinoma: an interpretable multidimensional model
- An interpretable computed tomography radiomics-based machine learning model for preoperative prediction of complicated appendicitis in children.
- Development and Patient-Level Internal Validation of an MRI-Based Radiomics Machine Learning Model for Preoperative Prediction of Cervical Lymph Node Metastasis in Oral Squamous Cell Carcinoma: A Pilot Study.
- Interpretable multimodal deep learning for time-resolved survival prediction after hepatocellular carcinoma resection
- Preoperative risk stratification for postoperative inflammatory–nutritional deterioration after colorectal cancer surgery: an interpretable machine learning study
BibTeX
@article{wang2026interpretable,
title = {{Interpretable machine learning for preoperative prediction of WHO/ISUP grade in clear cell renal cell carcinoma using contrast-enhanced CT–derived extracellular volume fraction}},
author = {Yating Wang and Ying Wang and Genji Bai and Wei Huang and Min Huang and Wei Chen},
journal = {Frontiers in Oncology},
year = {2026},
month = oct,
doi = {10.3389/fonc.2026.1851636},
url = {https://www.frontiersin.org/articles/10.3389/fonc.2026.1851636/full},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Interpretable machine learning for preoperative prediction of WHO/ISUP grade in clear cell renal cell carcinoma using contrast-enhanced CT–derived extracellular volume fraction
AU - Yating Wang
AU - Ying Wang
AU - Genji Bai
AU - Wei Huang
AU - Min Huang
AU - Wei Chen
PY - 2026
DA - 2026/10/13
JO - Frontiers in Oncology
DO - 10.3389/fonc.2026.1851636
UR - https://www.frontiersin.org/articles/10.3389/fonc.2026.1851636/full
AB - Objective: To develop and validate an interpretable machine learning (ML) model that integrates extracellular volume fraction (ECV) derived from contrast-enhanced CT with clinical and imaging features for preoperative prediction of World Health Organization/International Society of Urological Pathology (WHO/ISUP) grade in clear cell renal cell carcinoma (ccRCC). Materials and methods: A retrospective cohort of 263 patients with pathologically confirmed ccRCC from two institutions was analyzed. Patients from Hospital A (n=184) were randomly divided into training (n=128) and internal validation (n=56) cohorts, while patients from Hospital B (n=79) served as an independent external validation cohort. CT-derived ECV, arterial enhancement fraction (AEF), and conventional imaging features were extracted. Six machine learning models (Logistic Regression [LR], eXtreme Gradient Boosting [XGBoost], Gaussian Naive Bayes [GNB], Support Vector Machine [SVM], K-Nearest Neighbors [KNN], Light Gradient Boosting Machine [LightGBM]) were constructed, and the best-performing model was identified based on bootstrap resampling. Model interpretability was assessed using SHapley Additive exPlanations (SHAP). Results: Tumor size (low-grade: 4.99 ± 1.98 cm; high-grade: 6.20 ± 2.72 cm, P = 0.002), ECV (low-grade: 0.46 ± 0.09; high-grade: 0.57 ± 0.12, P<0.001), and AEF (low-grade: 1.37 ± 0.24; high-grade: 1.56 ± 0.25, P<0.001) were significantly higher in high-grade ccRCC, while hematocrit (HCT, low-grade: 0.41 ± 0.05; high-grade: 0.38 ± 0.06, P<0.001) was lower. The optimal LR model achieved robust performance: training cohort AUC = 0.995 (95% CI: 0.990–0.999), internal validation AUC = 0.903 (95% CI: 0.818–0.988), external test AUC = 0.857 (95% CI: 0.756–0.958). SHAP analysis showed ECV, tumor diameter, and AEF were the top 3 predictors. Conclusion: An interpretable ML model incorporating CT-derived ECV and imaging features effectively predicts preoperative WHO/ISUP grade of ccRCC, providing a noninvasive tool for individualized risk stratification and clinical decision-making.
SN - 2234-943X
ER -